Shilpa Medicare saw the highest growth of 99% in patent filings and 99% in grants in November in Q4 2023. Compared to Q3 2023, Q4 2023 saw an increase in patent filings by 99% and grants by 99%. GlobalData’s DataBook provides a comprehensive analysis of Shilpa Medicare’s patent filings and grants. Buy the databook here.
Go deeper with GlobalData
Shilpa Medicare has been focused on protecting inventions in Israel(IL) with two publications in Q4 2023
The Israel(IL) Patent Office dominates the patent filings and grants with nearly 50% filings and 33% grants. The Israel(IL), Australia(AU), United States(US), and European Patent Office(EPO) patent Office are among the top ten patent offices where Shilpa Medicare is filings its patents. Among the top granted patent authorities, Shilpa Medicare has 67% of its grants in United States(US) and 33% in Israel(IL).
Johnson & Johnson and F. Hoffmann-La Roche could be the strongest competitors for Shilpa Medicare
See Also:
Wounds related patents lead Shilpa Medicare portfolio
How well do you really know your competitors?
Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.
Thank you!
Your download email will arrive shortly
Not ready to buy yet? Download a free sample
We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form
By GlobalDataShilpa Medicare has highest number of patents in wounds.
For comprehensive analysis of Shilpa Medicare's filings and grants, buy the databook here.
